The Use of Splenectomy to Manage Platelet Transfusion Refractoriness Due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation
Abstract
Share and Cite
Mauro, M.; Camoglio, F.; Piccoli, P.; De Bortoli, M.; Balter, R.; Pegoraro, A.; Cesaro, S. The Use of Splenectomy to Manage Platelet Transfusion Refractoriness Due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation. Pediatr. Rep. 2016, 8, 6159. https://doi.org/10.4081/pr.2016.6159
Mauro M, Camoglio F, Piccoli P, De Bortoli M, Balter R, Pegoraro A, Cesaro S. The Use of Splenectomy to Manage Platelet Transfusion Refractoriness Due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation. Pediatric Reports. 2016; 8(1):6159. https://doi.org/10.4081/pr.2016.6159
Chicago/Turabian StyleMauro, Margherita, Francesco Camoglio, Pierluigi Piccoli, Massimiliano De Bortoli, Rita Balter, Anna Pegoraro, and Simone Cesaro. 2016. "The Use of Splenectomy to Manage Platelet Transfusion Refractoriness Due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation" Pediatric Reports 8, no. 1: 6159. https://doi.org/10.4081/pr.2016.6159
APA StyleMauro, M., Camoglio, F., Piccoli, P., De Bortoli, M., Balter, R., Pegoraro, A., & Cesaro, S. (2016). The Use of Splenectomy to Manage Platelet Transfusion Refractoriness Due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation. Pediatric Reports, 8(1), 6159. https://doi.org/10.4081/pr.2016.6159